You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD40L inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Tumor-infiltrating Lymphocytes (TIL)
  • +5 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 25, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (SL-172154)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +8 more
Feb 23, 2022

Type 1 Diabetes Trial in Vancouver (Frexalimab, Placebo, Insulin)

Recruiting
  • Type 1 Diabetes Mellitus
  • Vancouver, British Columbia, Canada
    Investigational Site Number : 1240001
Oct 31, 2023

Advanced / Metastatic Solid Tumors Trial (MAX-40279-01: 50mg/70mg)

Not yet recruiting
  • Advanced / Metastatic Solid Tumors
  • MAX-40279-01: 50mg/70mg
  • (no location specified)
Jun 16, 2022

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Cabozantinib S-malate
  • +7 more
  • (no location specified)
Jan 4, 2023

Liver Transplant Rejection Trial in Worldwide (CFZ533, Tacrolimus - MMF - corticosteroids)

Active, not recruiting
  • Liver Transplant Rejection
  • CFZ533
  • Tacrolimus - MMF - corticosteroids
  • Los Angeles, California
  • +28 more
Jan 17, 2023

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck Trial in United States (Drug: SL-172154)

Terminated
  • Cutaneous Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Head and Neck
  • Drug: SL-172154
  • Los Angeles, California
  • +5 more
May 18, 2022

Kidney Transplant Rejection Trial in Saint Louis, Richmond (AT-1501, Tacrolimus)

Recruiting
  • Kidney Transplant Rejection
  • Saint Louis, Missouri
  • +1 more
Aug 2, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium, France, Spain (CD40 agonist mitazalimab in combination with chemo)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • CD40 agonist mitazalimab in combination with chemotherapy
  • Brussels, Belgium
  • +15 more
Aug 12, 2022

Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +12 more
Jan 23, 2023

Recurrent DLBCL, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Houston (drug, procedure, other, biological)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Kidney Transplant Rejection Trial in Montréal (AT-1501, Tacrolimus)

Enrolling by invitation
  • Kidney Transplant Rejection
  • Montréal, Quebec, Canada
    McGill University Health Care Centre
Nov 6, 2023

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)

Recruiting
  • Solid Tumor
  • +9 more
  • MEM-288 Intratumoral Injection
  • Tampa, Florida
  • +1 more
Jun 27, 2022

Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Melanoma Stage Iii
  • +4 more
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jul 20, 2022

NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Phase I - Mirdametinib - Level 1
  • +4 more
  • (no location specified)
Jul 7, 2023

Real-life Current Standards of Care in Relapsed and/or

Completed
  • Multiple Myeloma
  • No intervention
  • Tucson, Arizona
  • +85 more
Dec 20, 2022

Thyroid Cancer Trial in Chengdu (Tislelizumab, Anlotinib, Radiotherapy)

Recruiting
  • Thyroid Cancer
  • Chengdu, Sichuan, China
    Xingchen Peng
Dec 17, 2022

Kidney Transplant Trial in Montréal (AT-1501)

Recruiting
  • Kidney Transplant
  • Montréal, Quebec, Canada
    McGill University Health Care Centre
May 16, 2022

Coronary Artery Disease Trial (Lansoprazole 15 mg)

Not yet recruiting
  • Coronary Artery Disease
  • Lansoprazole 15 mg
  • (no location specified)
Apr 6, 2023

Brittle Type 1 Diabetes Trial (AT-1501 IV Infusion, Isolated cadaveric islet cells)

Not yet recruiting
  • Brittle Type 1 Diabetes Mellitus
  • AT-1501 IV Infusion
  • Isolated cadaveric islet cells
  • (no location specified)
Jul 27, 2022

Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Kansas City, Kansas
  • +3 more
May 12, 2023

Advanced HCC Trial (Lenalidomide)

Not yet recruiting
  • Advanced HCC
  • (no location specified)
Apr 16, 2023